Cargando…

Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma

The tumor microenvironment (TME) is a complex multicellular functional compartment that includes fibroblasts, myofibroblasts, endothelial cells, immune cells, and extracellular matrix (ECM) elements. The microenvironment provides an optimum condition for the initiation, growth, and dissemination of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jie, Gu, Chaoyu, Song, Qianqian, Zhu, Mengqi, Xu, Yuqing, Xiao, Mingbing, Zheng, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603733/ https://www.ncbi.nlm.nih.gov/pubmed/33292459 http://dx.doi.org/10.1186/s13578-020-00488-y

Ejemplares similares

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination
por: Zhu, Mengqi, et al.
Publicado: (2021)

Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation
por: Bian, Saiyan, et al.
Publicado: (2022)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Organoids in recapitulating tumorigenesis driven by risk factors: Current trends and future perspectives
por: Zhang, Jie, et al.
Publicado: (2022)

Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast
por: Yang, Zhentao, et al.
Publicado: (2021)

An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma
por: Yao, Ninghua, et al.
Publicado: (2023)

Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
por: Zhang, Wei, et al.
Publicado: (2020)

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
por: Zheng, Wenjie, et al.
Publicado: (2016)

Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets
por: Wang, Haijun, et al.
Publicado: (2021)

Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
por: Akkız, Hikmet
Publicado: (2023)

Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
por: Zhang, Jianping, et al.
Publicado: (2023)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

Emerging agents and regimens for hepatocellular carcinoma
por: Zhu, Xiao-Dong, et al.
Publicado: (2019)

The androgen receptor as an emerging target in hepatocellular carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
por: Coleman, Stacey J, et al.
Publicado: (2014)

Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?
por: Zaki, Marco Y.W., et al.
Publicado: (2022)

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
por: Xu, Chenzhou, et al.
Publicado: (2018)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent
por: Kan, Anna, et al.
Publicado: (2018)

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
por: Lian, Jie, et al.
Publicado: (2022)

MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4
por: Li, Yun, et al.
Publicado: (2020)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
por: Lee, Carol, et al.
Publicado: (2019)

MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma
por: Shao, Yingjie, et al.
Publicado: (2019)

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Ying, Fan, et al.
Publicado: (2023)

Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19
por: Huang, Yongbiao, et al.
Publicado: (2022)

Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3
por: Zhu, Mengqi, et al.
Publicado: (2022)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma
por: Yuan, Xiaofeng, et al.
Publicado: (2022)

PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2019)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma
por: Sun, Renliang, et al.
Publicado: (2020)

The Long Noncoding RNA Expression Profile of Hepatocellular Carcinoma Identified by Microarray Analysis
por: Zhu, Juanjuan, et al.
Publicado: (2014)

Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma
por: Ma, Li‐Jie, et al.
Publicado: (2017)

Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy
por: Yang, Jiabin, et al.
Publicado: (2023)

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2023)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

Metastasis-associated fibroblasts: an emerging target for metastatic cancer
por: Wang, Zimu, et al.
Publicado: (2021)

A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma
por: Liu, Jinxia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_teqfgm5d9s5a214t76fbj9ubsd